Voya Investment Management LLC Jounce Therapeutics, Inc. Transaction History

Voya Investment Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.9 - $1.85 $123,647 - $254,164	-137,386 Reduced 88.26%	18,274 $33,000
Q4 2022 Feb 14, 2023	BUY	$0.64 - $1.99 $61,267 - $190,502	95,730 Added 159.74%	155,660 $172,000
Q3 2022 Mar 03, 2023	SELL	$2.73 - $4.92 $261,342 - $470,991	-95,730 Reduced 61.5%	59,930 $163,000
Q3 2022 Nov 14, 2022	BUY	$2.73 - $4.92 $20,616 - $37,155	7,552 Added 14.42%	59,930 $140,000
Q2 2022 Aug 15, 2022	BUY	$2.8 - $7.67 $58,055 - $159,029	20,734 Added 65.52%	52,378 $159,000
Q1 2022 May 16, 2022	SELL	$6.01 - $8.54 $1,508 - $2,143	-251 Reduced 0.79%	31,644 $215,000
Q4 2021 Feb 14, 2022	SELL	$7.11 - $9.64 $746 - $1,012	-105 Reduced 0.33%	31,895 $266,000
Q3 2021 Nov 15, 2021	BUY	$5.04 - $8.73 $1,547 - $2,680	307 Added 0.97%	32,000 $238,000
Q2 2021 Aug 16, 2021	BUY	$6.58 - $10.66 $80,085 - $129,742	12,171 Added 62.35%	31,693 $216,000
Q1 2021 May 17, 2021	BUY	$6.73 - $13.87 $131,383 - $270,770	19,522 New	19,522 $200,000

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.